For the year ending 2025-12-31, XAGEW made $1,912,811 in revenue. -$6,905,282 in net income. Net profit margin of -361.00%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net sales | 1,912,811 | |||
| Cost of sales | 818,051 | |||
| Gross profit | 1,094,760 | |||
| Selling and marketing | 1,423,045 | |||
| Research and development | 788,888 | |||
| General and administrative | 5,911,725 | |||
| Depreciation and amortization of intangible assets | 78,675 | |||
| Total operating expenses | 8,202,333 | |||
| Loss from operations | -7,107,573 | |||
| Other income | 168,146 | |||
| Interest expense | 18,214 | |||
| Change in fair value of earnout liabilities | -149,584 | |||
| Inventory write-down | 60,963 | |||
| Amortization of debt discount | 0 | |||
| Loss on forward purchase agreement | 0 | |||
| Loss on lease termination | 0 | |||
| Total other income (expense) | 238,553 | |||
| Loss from continuing operations before income taxes | -6,869,020 | |||
| Income tax expense (benefit) | 36,262 | |||
| Loss from continuing operations | -6,905,282 | |||
| Loss from discontinued operations, net of tax | 0 | |||
| Gain on sale of discontinued operations | 0 | |||
| Net loss | -6,905,282 | |||
| Basic EPS | -4.83 | |||
| Diluted EPS | -4.83 | |||
| Basic Average Shares | 1,429,557 | |||
| Diluted Average Shares | 1,429,557 | |||
Longevity Health Holdings, Inc. (XAGEW)
Longevity Health Holdings, Inc. (XAGEW)